论文信息 - A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus. - 字舞流文

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus.

M. Petri | D. Wallace | J. Merrill | W. Mccune | W. Stohl | R. Furie | W. Chatham | W. Freimuth | J. Lisse | E. Ginzler | Z. Zhong | W. Chatham | M. Chevrier | Vivian Fernández | J. McKay | Vivian Fernandez | W. McCune | J. McKAY | Daniel J. Wallace | Jeffrey R. Lisse | Michelle A. Petri | W. Joseph McCune | Marc R. Chevrier | J. Lisse | W. J. McCune